... data remain immature at the time of premature study closure. Adjuvant immunotherapy trials, including IMvigor010, CheckMate 274, and AMBASSADOR, have not shown a definitive benefit in UTUC subgroup analyses, a finding that may reflect limited statistical power. Persistent challenges include inaccurate...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Natural killer cells Renal cell carcinoma Adjuvant immunotherapy Cytotoxic lymphocytes Urol. int. 40: 251-256 (1985) © 1985 S. Karger AG, Basel 0042-1138/85/0405-0251...

... significantly lower activity than patients in remission or with stable disease. Hormone therapy was without major influence on NK activity. BCG vaccination as an adjuvant immunotherapy was done in a small group of patients. Baseline NK activity and interferon-stimulated activity were enhanced by BCG in most...